Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2014
05/07/2014CN103767929A 一种中药三七蛋白调理香波 A traditional Chinese medicine thirty-seven protein conditioning shampoo
05/07/2014CN103767927A 一种中药三七乌金营养香波 A traditional Chinese medicine thirty-seven Ugyen Nutrition Shampoo
05/07/2014CN103315973B 喹硫平的渗透泵型控释制剂 Quetiapine osmotic pump controlled release formulation
05/07/2014CN103223038B 一种用于温肾健脾的中药组合物及其制备方法 Chinese medicine composition and its preparation method for warming kidney and spleen
05/07/2014CN103169889B 一种治疗抑郁症的中药 A traditional Chinese medicine treatment of depression
05/07/2014CN103141628B 一种班叶兰根保健茶 One kind Ban Eran root health tea
05/07/2014CN103127336B 一种治疗顽固性头痛的中药制剂 A method of treating intractable headache medicine preparations
05/07/2014CN103110902B 一种治疗中风后抑郁症的中药足浴液 A method of treating post-stroke depression medicine foot bath
05/07/2014CN103099888B 一种消除疲劳、改善睡眠、增强体力足浴包及其制备工艺 Way to eliminate fatigue, improve sleep, enhance physical Foot Pack and preparation process
05/07/2014CN103083548B 一种保健足浴包及其制备工艺 A health Foot Pack and preparation process
05/07/2014CN103083530B 一种治疗臂丛神经痛的中药 A traditional Chinese medicine treatment of brachial neuralgia
05/07/2014CN103041180B 一种治疗低颅压综合征的中药组合物 A Chinese medicine composition for the treatment of intracranial hypotension syndrome
05/07/2014CN102964279B 一类具有外周镇痛作用的κ阿片受体激动剂 A class of κ opioid receptor has a peripheral analgesic effect of agonists
05/07/2014CN102940857B 一种治疗抑郁症的药物组合物及其制备方法 A method of treating depression pharmaceutical composition and its preparation method
05/07/2014CN102920783B 一种五味子有效部位的制备工艺 A process for the preparation of effective parts of Schisandra
05/07/2014CN102898322B 一种化合物及其制法和用途 A compound preparation and use
05/07/2014CN102883716B 改善伴有学习/记忆障碍和运动障碍等的中枢神经变性疾病的干燥植物组织和植物组织提取物以及含有它们的药品和食品 Improvements associated with learning / memory disorders and movement disorders and other degenerative diseases of the central nervous dried plant tissue and plant tissue extracts as well as medicines and food containing them
05/07/2014CN102872212B 肝脏x受体激动剂的筛选方法 The screening method of the liver x receptor agonists
05/07/2014CN102861106B 一种复方氨酚烷胺微丸的制备方法 A method for preparing alkyl amine compound paracetamol pellets
05/07/2014CN102813886B 一种治疗偏头痛的中药制剂 A method of treating migraine medicine preparations
05/07/2014CN102776129B 一株头棒束孢霉及其应用 A head bundle Neurospora crassa and Its Application
05/07/2014CN102727475B 视黄酸及其衍生物在制备防治老年痴呆药物中的应用 Retinoic acid and its derivatives in the preparation of a medicament for the prevention and treatment of Alzheimer's Application
05/07/2014CN102719443B 一种羧基末端特异的抗人淀粉样蛋白单克隆抗体基因和其编码多肽及应用 One kind of the carboxyl-terminal human-specific anti-amyloid monoclonal antibody genes and their encoded polypeptides and Applications
05/07/2014CN102716346B 解毒戒毒药物 Drug detoxification treatment
05/07/2014CN102716171B 一种穿心莲复方掩味颗粒及其制备方法 A COMPOUND taste masking particles and preparation method Andrographis
05/07/2014CN102712622B α7nAChR的吲哚衍生物调节剂 α7nAChR indole derivatives modifier
05/07/2014CN102626396B 一种美托洛尔缓释片剂及其制备方法 One kind of metoprolol extended-release tablets and its preparation method
05/07/2014CN102600375B 一种治疗帕金森病运动并发症的药物及其应用 A treatment for Parkinson's disease and motor complications of drug use
05/07/2014CN102552436B 一种治疗焦虑抑郁障碍的药物及其应用 A method of treating anxiety and depression drugs and their applications
05/07/2014CN102516359B 一种抗老年痴呆症先导化合物 A lead compound for anti-Alzheimer's disease
05/07/2014CN102459232B 7-氮杂-螺[3.5]壬烷-7-甲酸酯衍生物、其制备及其治疗用途 7-aza - spiro [3.5] nonane-7-carboxylic acid ester derivatives, their preparation and their therapeutic use
05/07/2014CN102341388B 作为γ分泌酶调节剂的取代苯并*唑、苯并咪唑、*唑并吡啶和咪唑并吡啶衍生物 As the γ-secretase modulators substituted benzo * indazole, benzimidazole, oxazole, and pyridine and imidazole * pyridine derivative
05/07/2014CN102320928B 一种杜仲活性单体化合物、制备方法、药物组合物及其用途 One kind of Eucommia active monomer compound, preparation, pharmaceutical compositions and uses thereof
05/07/2014CN102240388B 一种姜提取物、其制备方法及其用途 One kind of ginger extract, their preparation and their use
05/07/2014CN102217885B 治疗神经性头痛的中药枕 Nervous headache treatment in pillow
05/07/2014CN102159582B 作为Edg-1受体激动剂的噁唑并嘧啶 Edg-1 receptor agonists as oxazole pyrimidine
05/07/2014CN102088987B 利用番石榴治疗偏头痛的方法 Use guava method of treatment of migraine
05/07/2014CN102036989B 6-杂芳基咪唑并[1,2-a]吡啶的多取代衍生物及其制备方法和治疗用途 6- heteroaryl imidazo [1,2-a] pyridine derivatives and polysubstituted preparation and therapeutic use
05/07/2014CN102007129B 用作治疗人类脑疾病的前药的雪花胺衍生物 Used as the pre-treatment of human brain diseases drug galantamine derivatives
05/07/2014CN101981443B 抑肝散的生物测定方法 Suppression of hepatic scattered bioassay method
05/07/2014CN101910157B 吲哚化合物和治疗内脏痛的方法 And methods for treating visceral pain indole compound
05/07/2014CN101869553B 一种盐酸安非他酮缓释片及其制备方法 One kind of bupropion hydrochloride sustained-release tablets and its preparation method
05/07/2014CN101855200B N-[4-(三氟甲基)苯甲基]-4-甲氧基丁酰胺的多晶型物 N- [4- (trifluoromethyl) benzyl] -4-methoxybutyramide polymorph
05/07/2014CN101701032B 具有抑制基质金属蛋白酶作用的喹喔啉酮小分子类肽衍生物及其制备方法和应用 Inhibit matrix metalloproteinase role quinoxaline-ketone derivatives and their preparation and application of small molecules peptoids
05/07/2014CN101384172B N-[2,4-双(1,1-二甲基乙基)-5-羟基苯基]-1,4-二氢-4-氧代喹啉-3-甲酰胺的固体形式 N- [2,4- bis (1,1-dimethylethyl) -5-hydroxyphenyl] -1,4-dihydro-4-oxo-quinoline-3-carboxamide in the form of a solid
05/06/2014US8716493 Multicyclic compounds and the use thereof
05/06/2014US8716486 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
05/06/2014US8716445 Compositions comprising signal peptide-containing proteins
05/06/2014US8716323 Cyclic protein tyrosine kinase inhibitors
05/06/2014US8716321 Methods for dosing an orally active 1,2,4-oxadiazole
05/06/2014US8716276 Thiophenyl and pyrrolyl azepines as serotonin 5-HT2C receptor ligands and uses thereof
05/06/2014US8716269 Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and related disorders
05/06/2014US8716215 Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease
05/06/2014US8715968 Methods and reagents for modulating cholesterol levels
05/06/2014US8715721 Controlled release hydrocodone
05/06/2014US8715699 Amino acid conjugates of quetiapine, process for making and using the same
05/06/2014US8715668 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 and uses thereof
05/06/2014CA2658379C Spirocyclic azaindole derivatives
05/06/2014CA2646899C Use of compositions containing kappa-opioid receptor antagonists for the treatment of dissociative disorders
05/06/2014CA2631816C Compounds with medicinal effects due to interaction with the glucocorticoid receptor
05/01/2014WO2014066695A1 Compositions and methods for treating estrogen-related medical disorders
05/01/2014WO2014066686A1 Brain targets for neurotrophic factors to treat neurodegenerative disease
05/01/2014WO2014066659A1 Heteroaryl inhibitors of pde4
05/01/2014WO2014066318A1 Combination therapies for the treatment of alzheimer's disease and related disorders
05/01/2014WO2014066304A1 Compositions and methods for treating or preventing diseases or disorders associated with misregulated eif4e
05/01/2014WO2014066208A1 Levodopa formulations for rapid relief of parkinson's disease
05/01/2014WO2014066132A1 Bace inhibitors
05/01/2014WO2014065710A1 (3-arylsulfonyl-quinoline-8-yl)-dialkyl-amines as selective antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof
05/01/2014WO2014065669A1 Methods of treatment and diagnosis for cognitive decline and memory impairment
05/01/2014WO2014065606A1 Agent for treating nerve disease, comprising osmotin composition and inhibitor for inhibiting expression or activity of gaba b receptor proteins
05/01/2014WO2014065434A1 Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity
05/01/2014WO2014065413A1 Triazole-isoxazole compound and medical use thereof
05/01/2014WO2014065348A1 Novel method for treating spinal cord injury using hmgb1 fragment
05/01/2014WO2014065270A1 Tetrahydrooxazolo-pyridine derivative
05/01/2014WO2014065194A1 Nerve growth inhibitor, cutaneous-sensory-irritation inhibitor, and marker for cutaneous-sensory-irritation detection
05/01/2014WO2014064258A1 Compositions and methods for selective delivery of oligonucleotide molecules to cell types
05/01/2014WO2014064257A1 Compositions and methods for the treatment of parkinson disease by the selective delivery of oligonucleotide molecules to specific neuron types
05/01/2014WO2014064166A1 Mixed inhibitors of aminopeptidase n and of neprilysine
05/01/2014WO2014064162A1 Neprilysin inhibitors
05/01/2014WO2014064038A1 Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine d3 receptor
05/01/2014WO2014064028A1 Mglu2/3 antagonists for the treatment of autistic disorders
05/01/2014WO2014063587A1 Fluorine substituted cyclic amine compounds and preparation methods, pharmaceutical compositions, and uses thereof
05/01/2014WO2014063312A1 Use of salvianolic acid a in prevention and/or treatment of cerebral microvascular thromboembolic disease
05/01/2014WO2014063199A1 Organic compounds
05/01/2014WO2014039074A3 Therapeutic compositions and related methods
05/01/2014WO2014037834A3 Compositions and methods for treatment of inflammation and lipid disorders
05/01/2014WO2014037832A3 Compositions and methods for treatment of epilepsy and neurological diseases
05/01/2014WO2014036182A3 Diagnosis and treatment of autism spectrum disorder
05/01/2014WO2014018563A3 Methods for the treatment of cancer
05/01/2014US20140121284 Stable Pharmaceutical Composition
05/01/2014US20140121283 Methods of using derivatives of (-)-venlafaxine
05/01/2014US20140121254 Pharmaceutical compositions for the treatment of movement disorders
05/01/2014US20140120188 Composition for preventing and/or alleviating hangover comprising extracts of sophora flavescens
04/2014
04/30/2014EP2725105A1 Enzymatic production method for brain-function-improving peptides
04/30/2014EP2725018A1 Substituted cinnamamide derivative, preparation method and use thereof
04/30/2014EP2725013A1 Novel histone deacetylase inhibitor of benzamides and use thereof
04/30/2014EP2724723A1 Tegaserod for use in the treatment of nerve injuries
04/30/2014EP2724721A1 Composition for use in the treatment of Angelman syndrome and/or autism spectrum disorder, the use of such composition and a method for manufacturing a medicament for the treatment of Angelman syndrome and/or autism spectrum disorder
04/30/2014EP2723866A1 Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease
04/30/2014EP2723864A2 Phenocopy model of disease
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 1833